FDA new drug approvals in Q3 2020

被引：3

|

作者：

Urquhart, Lisa ^{[1
]}

机构：

[1] Evaluate Vantage, London, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2020年 / 19卷 / 11期

关键词：

D O I：

10.1038/d41573-020-00182-1

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：746 / 746

页数：1

相关论文

共 50 条

[31] FDA Guidance and New Drug Approvals
Walker, Scot
HOSPITAL PHARMACY, 2018, 53 (06) : 360 - 362
[32] 2020 in review: FDA approvals of new medicines
Kinch, Michael S.
Kraft, Zachary
Schwartz, Tyler
DRUG DISCOVERY TODAY, 2021, 26 (12) : 2794 - 2799
[33] MARKET WATCH FDA new drug approvals in Q2 2019
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (08) : 575 - 575
[34] MARKET WATCH FDA new drug approvals in Q2 2022
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (08) : 550 - 550
[35] MARKET WATCH FDA new drug approvals in Q2 2021
Urquhart, Lisa
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (08) : 578 - 578
[36] FDA marks record year for new drug approvals
Challener, Cynthia A.
Pharmaceutical Technology, 2019, 43 (01) : 30 - 33
[37] 2016 FDA drug approvals
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) : 73 - 76
[38] 2015 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2016, 15 : 73 - 76
[39] 2013 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2014, 13 : 85 - 89
[40] 2014 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2015, 14 : 77 - 81

← 1 2 3 4 5 →